Determination of intraluminal theophylline concentrations after oral intake of an immediate-and a slow-release dosage form
- 1 August 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (8) , 987-995
Abstract
The purpose of this study was to evaluate a protocol which enables determining luminal drug concentrations after oral drug administration in man. Human intestinal fluids were aspirated from two sampling sites (duodenum and jejunum) at different time points after oral intake of theophylline; an immediate- and a slow-release dosage form were used to demonstrate the feasibility of discriminating between different formulations. Osmolarity and pH of the aspirates were measured and theophylline concentrations were determined by HPLC-UV. After intake of the immediate-release formulation of theophylline, duodenal maximum concentrations up to 3 mm were reached within 30 min. Theophylline appeared to be almost completely absorbed before it reached the second sampling site in the jejunum, as observed jejunal concentrations were lower than 10% of the maximal duodenal concentrations. These results are in agreement with fast dissolution and fast absorption through the intestinal mucosa, which could be expected as theophylline belongs to class I of the Biopharmaceutical Classification System. In contrast to the immediate-release formulation, administering the slow-release dosage form resulted in a gradual appearance of theophylline, reaching maximal intestinal concentrations below 300 μm. The proposed methodology can be used to assess luminal drug concentrations and to monitor the time- and site-dependent composition of intestinal fluids after intake of an oral dosage form. This approach may contribute to a better understanding of the behaviour of oral drug formulations in the gastrointestinal tract and may be exploited to further unravel the complexity of the gastrointestinal absorption process. In addition, knowledge of luminal drug concentrations may assist in the selection of drug concentrations applied in in-vitro permeability assays.Keywords
This publication has 27 references indexed in Scilit:
- Hydrodynamics-induced variability in the USP apparatus II dissolution testInternational Journal of Pharmaceutics, 2005
- A Pilot Study on Duodenal Acid Exposure and Its Relationship to Symptoms in Functional Dyspepsia with Prominent NauseaAmerican Journal of Gastroenterology, 2004
- Ritonavir–PEG 8000Amorphous Solid Dispersions: In vitro and In vivo EvaluationsJournal of Pharmaceutical Sciences, 2004
- Intestinal Drug Transporters: In Vivo Function and Clinical ImportanceCurrent Drug Metabolism, 2004
- Prediction of plasma concentration–time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteersInternational Journal of Pharmaceutics, 2002
- Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut®) in humansEuropean Journal of Pharmaceutical Sciences, 2001
- A comparison between direct determination of in vivo dissolution and the deconvolution technique in humansEuropean Journal of Pharmaceutical Sciences, 1999
- Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II DrugsPharmaceutical Research, 1998
- A new approach for direct in vivo dissolution studies of poorly soluble drugs.Pharmaceutical Research, 1997
- Variability of gastrointestinal transit in healthy women and men.Gut, 1996